TITLE

Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia

AUTHOR(S)
Somberg, J.C.; Bailin, S.J.; Haffajee, C.I.; Hamaad, Ali
PUB. DATE
May 2003
SOURCE
ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Summarizes a study that analyzed the efficacy of intravenous water-soluble amiodarone for improving 24-hour survival in patients with incessant ventricular tachycardia. Characterization of the patients; Main outcome measures; Results of the study.
ACCESSION #
9874859

 

Related Articles

  • Rapid control of recurrent ventricular tachycardia with oral amiodarone. Mattison, Paul; Rodger, J. Christine // British Medical Journal (Clinical Research Edition);10/2/1982, Vol. 285 Issue 6346, p939 

    Examines the use of amiodarone in the treatment of ventricular tachycardia. Therapeutic effect of the drug; Number of hours of drug effectivity; Accumulation of the medicine within the tissues.

  • Amiodarone.  // Reactions Weekly;Dec2014, Vol. 1532 Issue 1, p23 

    The article presents a case report of a male patient who developed euthyroid goiter during treatment with amiodarone for ventricular tachycardia (VT).

  • Amiodarone in Patients with Heart Failure. Breithardt, Gunter // New England Journal of Medicine;7/13/95, Vol. 333 Issue 2, p121 

    Editorial. Discusses the reasons behind the different results of the Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure and the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) study concerning the use of amiodarone as...

  • Adverse reactions during treatment with amiodarone hydrochloride. McGovern, Brian; Garan, Hasan; Kelly, Elizabeth; Ruskin, Jeremy N. // British Medical Journal (Clinical Research Edition);7/16/1983, Vol. 287 Issue 6386, p175 

    Investigates on the adverse reactions during treatment with amiodarone hydrochloride. Administration of amiodarone on 80 patients with recurrent cardiac tachyarrhythmias; Treatment of 49 patients for ventricular tachycardia or fibrillation; Side-effects of drugs; Use of antiarrhythmic drugs.

  • This drug needs close monitoring. Porterfield, Linda M.; Cerrato, Paul L. // RN;Jul96, Vol. 59 Issue 7, p71 

    Determines the type of nursing intervention needed in the case of a 66-year-old male myocardial infarction (MI) patient given amiodarone intravenously for suppressing sustained ventricular tachycardia. Infusion of 100-500 cc of fluid to raise the blood pressure.

  • Amiodarone.  // Reactions Weekly;10/29/2016, Vol. 1625 Issue 1, p25 

    The article presents a case study of a 26-year old woman who developed alveolar haemorrhage causing fever, hemosputum and hypoxaemia during treatment with amiodarone for non-sustained ventricular tachycardia.

  • Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. Harayama, Nobuya; Nihei, Shun-ichi; Nagata, Keiji; Isa, Yasuki; Goto, Kei; Aibara, Keiji; Kamochi, Masayuki; Sata, Takeyoshi // Journal of Anesthesia;Aug2014, Vol. 28 Issue 4, p587 

    Purpose: Nifekalant is a pure potassium channel blocker that has been used to treat ventricular tachyarrhythmias since 1999 in Japan. Intravenous amiodarone was approved later than nifekalant in Japan, and it is still unclear which of the two agents is superior. The aim of this study was to...

  • Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment? Tomlinson, D. R.; Cherian, P.; Betts, T. R.; Bashir, Y. // Emergency Medicine Journal;Jan2008, Vol. 25 Issue 1, p15 

    The article presents a study which examined the efficacy of bolus dose intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained monomorphic ventricular tachycardia (VT). It considered patients identified by a database of admissions to the Coronary Care...

  • Combined mexiletine and propranolol treatment of refractory ventricular tachycardia. Leahey, Edward B.; Heissenbuttel, Robert H.; Giardina, Elsa Grace V.; Begger, J. Thomas // British Medical Journal;8/2/1980, Vol. 281 Issue 6236, p357 

    Investigates the effectivity of combined mexiletine and propranolol in treating patients with symptomatic ventricular tachycardia. Symptoms of syncope in patients; Definition of drug failure in the study; Limitation in the use of mexiletine.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics